Vaxess

Vaxess Technologies is a biotechnology company that is commercializing a patented technology using silk proteins to stabilize vaccines, allowing them to be stored and transported without refrigeration, and employing a novel microneedle sustained-release technology to improve vaccine delivery. Vaxess Technologies is developing the MIMIX™ sustained-release patch technology, an effective vaccine and treatment method.